0317 0647241

WhatsApp & Call 24/7

Palbociclib 125mg Capsule (Palbocent) Price in Pakistan | Impo Medic

₨ 0

Description

Palbociclib 125mg Capsule (Palbocent) Price in Pakistan 

Palbociclib 125mg Capsule (Palbocent) is a prescription targeted oncology medicine used to treat adults with hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2−) advanced or metastatic breast cancer. It belongs to a group of medicines called cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors. Palbociclib helps slow cancer cell growth by interfering with proteins responsible for cell division. It is generally prescribed in combination with hormone therapy under an oncologist’s supervision.

Palbocent contains 125mg of palbociclib per capsule and is listed in a pack of 21 capsules. The product has been listed in Pakistan by Sartaj Pharma, India. However, an official Palbocent product leaflet available online is issued by Incepta Pharmaceuticals, Bangladesh. These sources do not conclusively establish the manufacturer of the specific pack being sold as Sartaj Pharma. Check the manufacturer’s name and country printed on the actual pack before publishing those details as confirmed.

Uses of Palbociclib

Palbociclib is used for eligible adults with HR-positive, HER2-negative advanced or metastatic breast cancer. It is combined with appropriate endocrine treatment to help control disease progression.

  • Advanced Breast Cancer: Used with an aromatase inhibitor as initial endocrine-based treatment in eligible patients.

  • Metastatic Breast Cancer: Used with fulvestrant when the cancer has progressed following previous endocrine therapy.

  • Hormone Receptor-Positive Breast Cancer: Helps manage cancers that express hormone receptors and may respond to hormonal treatment.

The treatment combination depends on the patient’s diagnosis, menopausal status, previous treatment, and medical condition. Palbociclib is not suitable for every type of breast cancer.

How Palbociclib Works

Palbociclib selectively blocks CDK4 and CDK6 proteins, which help regulate cell division. In certain breast cancer cells, these proteins contribute to uncontrolled multiplication.

By inhibiting CDK4/6, palbociclib interferes with the progression of cancer cells from the G1 phase to the S phase of the cell cycle. This slows their multiplication. When combined with endocrine therapy, it helps control the growth of eligible HR-positive, HER2-negative breast cancer.

Dosage and Administration

The usual reference dose for adults is 125mg once daily for 21 consecutive days, followed by 7 days without treatment, completing a 28-day cycle. The capsule should be taken with food and used with the hormone therapy prescribed by the oncologist.

  • Take Palbocent at approximately the same time each day.

  • Swallow the capsule whole with food and water.

  • Do not open, crush, chew, or break the capsule.

  • If vomiting occurs or a dose is missed, do not take an extra dose that day.

  • Follow the specialist’s instructions for the next scheduled dose.

Depending on blood counts and treatment tolerance, the oncologist may reduce the dose to 100mg or 75mg, interrupt treatment, or discontinue it. Do not change the dose yourself.

Precautions

Palbociclib requires regular medical monitoring. Inform the doctor about existing medical conditions, allergies, pregnancy, breastfeeding, and all medicines or supplements being used.

  • Low white blood cell counts: Neutropenia is common and may increase infection risk. Regular complete blood count tests are important.

  • Infections: Report fever, chills, or signs of infection promptly.

  • Lung complications: Report new cough or breathing difficulty because pneumonitis or interstitial lung disease may occur.

  • Liver function: Liver enzyme changes may require monitoring.

  • Pregnancy: Palbociclib may harm an unborn baby. Discuss contraception with the treating specialist.

  • Drug interactions: Certain CYP3A medicines can affect palbociclib levels. Avoid grapefruit and grapefruit juice during treatment.

Palbociclib 125mg Capsule side effects include fatigue, nausea, diarrhoea, mouth sores, hair thinning, rash, anaemia, infections, and reduced white blood cell counts.

Product Information

  • Product Name: Palbocent

  • Generic Name: Palbociclib

  • Strength: 125mg

  • Dosage Form: Capsule

  • Pack Size: 21 Capsules

  • Listed Supplier/Brand Listing: Sartaj Pharma

  • Country Listed: India

  • Therapeutic Category: Oncology Medicine

  • Drug Class: CDK4/6 Inhibitor

  • Route of Administration: Oral

FAQs about Palbociclib 125mg Capsule (Palbocent) Price in Pakistan

1. What is Palbociclib125 mg Capsule used for?

It is used with hormone therapy for eligible adults with HR-positive, HER2-negative advanced or metastatic breast cancer.

2. What is the generic name of Palbocent?

Its generic name is Palbociclib 125mg Capsule, and each capsule contains 125mg.

3. What is the pack size of Palbocent 125mg?

The listed pack contains 21 capsules.

4. What is the Palbocent 125mg price in Pakistan?

The Palbocent price in Pakistan may vary with supplier and stock. Contact Impo Medic for the current Palbocent price.

5. Is Palbociclib available in Pakistan?

Availability depends on stock and supply. Contact Impo Medic to check whether Palbocent or another palbociclib brand is available.

Buy Palbocent 125mg Capsule Online in Pakistan

Looking for Palbocent price in Pakistan, Palbocent 125mg price, Palbociclib price, or Palbociclib 125mg price? Contact Impo Medic to check current pricing and Palbocent availability in Pakistan. Patients and healthcare professionals can enquire about Palbociclib availability, product details, and stock before ordering. This prescription oncology medicine should only be used under the supervision of a qualified oncologist.

Reviews

There are no reviews yet.

Be the first to review “Palbociclib 125mg Capsule (Palbocent) Price in Pakistan | Impo Medic”

Your email address will not be published. Required fields are marked *